These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4750116)

  • 1. [Neuropsychiatry in 1973].
    Lereboullet J; Rosa A; Olivier-Martin R
    Rev Prat; 1973 Apr; 23(23):2025-49. PubMed ID: 4750116
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neurological and psychiatric complications during cardiovascular pathology].
    Savagnone E; Muratore E
    Acta Neurol (Napoli); 1970; 25(1):83-115. PubMed ID: 4910697
    [No Abstract]   [Full Text] [Related]  

  • 3. [Guidelines recommend aspirin/dipyridamole retard in high recurrence risk. Well protected from the second stroke].
    Schwab S
    MMW Fortschr Med; 2009 Jul; 151(30-33):60-1. PubMed ID: 19722467
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet emboli and ischemia in rabbit's brain caused by ADP or arachidonic acid and the protective effect of ASA and dipyridamole.
    Fieschi C; Volante F
    Biochem Exp Biol; 1977; 13(3):315-9. PubMed ID: 16296015
    [No Abstract]   [Full Text] [Related]  

  • 5. [Post-anoxic myoclonus and similar myoclonic syndromes. Search for a common denominator].
    Fau R; Garrel S; Perret J
    Encephale; 1969; 58(2):158-78. PubMed ID: 5376428
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preventive drug therapy of transient cerebral ischemic attacks].
    Sørensen PS; Marquardsen J
    Ugeskr Laeger; 1982 Aug; 144(32):2357-60. PubMed ID: 7147462
    [No Abstract]   [Full Text] [Related]  

  • 7. [Secondary prevention of ischemic insult and transient cerebral ischemia. Is ASS alone enough?].
    Diener HC
    MMW Fortschr Med; 2003 May; 145 Suppl 2():111. PubMed ID: 14579505
    [No Abstract]   [Full Text] [Related]  

  • 8. [After stroke or TIA. Double protection by second platelet inhibitor].
    MMW Fortschr Med; 2003 Dec; 145(50):57. PubMed ID: 14963978
    [No Abstract]   [Full Text] [Related]  

  • 9. [Post-anoxia rhythmic myoclonic discharges].
    Baldy-Moulinier M; Cadilhac J; Passouant P
    Rev Neurol (Paris); 1968 Jun; 118(6):487-9. PubMed ID: 5724651
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial].
    Guiraud-Chaumeil B; Rascol A; David J; Boneu B; Clanet M; Bierme R
    Rev Neurol (Paris); 1982; 138(5):367-85. PubMed ID: 6815756
    [No Abstract]   [Full Text] [Related]  

  • 11. ["A.I.C.L.A." controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Part I: Protocol (author's transl)].
    Bousser MG; Eschwege E; Haguenau M; Lefauconnier JM; Touboul D; Touboul PJ
    Rev Neurol (Paris); 1981; 137(5):333-41. PubMed ID: 7027408
    [No Abstract]   [Full Text] [Related]  

  • 12. Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke.
    Thijs V; Lemmens R; Fieuws S
    Eur Heart J; 2008 May; 29(9):1086-92. PubMed ID: 18349026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma thromboglobulin and platelet aggregation index in transient ischaemic attack: effect of aspirin and dipyridamole therapy.
    Aushri Z; Berginer V; Nathan I; Dvilansky A
    Int J Clin Pharmacol Res; 1983; 3(5):339-42. PubMed ID: 6206005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of dipyridamole in patients with recent stroke or TIA.
    Bernstein RA
    Am Fam Physician; 2005 Aug; 72(3):382, 384; author reply 384. PubMed ID: 16100852
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [anti-platelet therapy or anti-coagulants as prevention in transient ischemic attacks and reversible ischemic stroke].
    Brechter C; Bäcklund H; Krook H; Müller R; Nitelius E; Olsson JE; Olsson O; Thornberg A
    Lakartidningen; 1980 Dec; 77(52):4947-56. PubMed ID: 7010029
    [No Abstract]   [Full Text] [Related]  

  • 18. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
    Gebel JM
    J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. For your stroke-prone patients: a guide to drug treatment.
    Yatsu FM
    Geriatrics; 1980 Feb; 35(2):34-47. PubMed ID: 7356588
    [No Abstract]   [Full Text] [Related]  

  • 20. [Summary of the practice guideline 'TIA' (first revision) from the Dutch College of General Practitioners].
    Houben J
    Ned Tijdschr Geneeskd; 2005 May; 149(21):1190-1; author reply 1191. PubMed ID: 15940927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.